MedPath

European Organisation For Research & Treatment Of Cancer

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.eortc.be

Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer

Phase 2
Terminated
Conditions
Bladder Cancer
First Posted Date
2004-04-09
Last Posted Date
2012-03-06
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
43
Registration Number
NCT00003642
Locations
🇫🇷

Institut Bergonie, Bordeaux, France

🇫🇷

CHR de Grenoble - La Tronche, Grenoble, France

🇳🇱

Dr. Bernard Verbeeten Instituut, Tilburg, Netherlands

OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer

Phase 1
Completed
Conditions
Colorectal Cancer
First Posted Date
2004-04-08
Last Posted Date
2013-06-12
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
15
Registration Number
NCT00081237
Locations
🇬🇧

Christie Hospital N.H.S. Trust, Manchester, England, United Kingdom

🇩🇪

Medizinische Hochschule Hannover, Hannover, Germany

Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus

Completed
Conditions
Esophageal Cancer
First Posted Date
2004-03-22
Last Posted Date
2013-06-12
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
370
Registration Number
NCT00003321
Locations
🇫🇷

Clinique Armoricaine De Radiologie, Saint Brieux, France

🇫🇷

Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France

🇦🇺

Sir Charles Gairdner Hospital, Perth, Perth, Western Australia, Australia

and more 7 locations

Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 2
Completed
Conditions
Brain and Central Nervous System Tumors
First Posted Date
2004-03-17
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
32
Registration Number
NCT00014300
Locations
🇫🇷

Centre Jean Perrin, Clermont-Ferrand, France

🇫🇷

CRLCC Nantes - Atlantique, Nantes-Saint Herblain, France

🇫🇷

Centre Antoine Lacassagne, Nice, France

and more 15 locations

Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract

Phase 2
Completed
Conditions
Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter
Urethral Cancer
First Posted Date
2004-03-16
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
21
Registration Number
NCT00006026
Locations
🇫🇷

Centre de Lute Contre le Cancer,Georges-Francois Leclerc, Dijon, France

🇮🇹

Azienda Ospedaliera di Padova, Padova (Padua), Italy

🇫🇷

Centre Henri Becquerel, Rouen, France

and more 8 locations

Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
First Posted Date
2004-03-15
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
15
Registration Number
NCT00004151
Locations
🇮🇹

Istituto Nazionale per lo Studio e la Cura dei Tumori, Naples, Italy

🇩🇪

Haemato-Onkologische Praxis und Tagesklinik, Munich, Germany

🇫🇷

CHU de la Timone, Marseille, France

and more 5 locations

Quality-of-Life Assessment in Patients With Ovarian Cancer

Completed
Conditions
Ovarian Cancer
First Posted Date
2004-03-15
Last Posted Date
2012-08-27
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
372
Registration Number
NCT00003772
Locations
🇪🇸

Hospital De Navarra, Pamplona, Spain

🇦🇹

Landeskrankenhaus/Universitatskliniken Graz, Graz, Austria

🇫🇷

Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France

and more 1 locations

Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Phase 3
Completed
Conditions
Sarcoma
First Posted Date
2004-03-12
Last Posted Date
2012-01-20
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
780
Registration Number
NCT00003212
Locations
🇩🇪

Klinikum Grosshadern, Munich, Germany

🇵🇱

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

🇪🇸

Hospital Insular de Gran Canaria, Las Palmas, Spain

and more 20 locations

Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus

Phase 3
Completed
Conditions
Endometrial Cancer
Sarcoma
First Posted Date
2004-03-11
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
224
Registration Number
NCT00002459
Locations
🇪🇸

Instituto Valenciano De Oncologia, Valencia, Spain

🇮🇹

Ospedale Civile, Voghera (PV), Italy

🇸🇪

University Hospital of Linkoping, Linkoping, Sweden

and more 25 locations

Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Lymphoma
Small Intestine Cancer
First Posted Date
2004-03-10
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
25
Registration Number
NCT00079261
Locations
🇭🇷

University Hospital Rebro, Zagreb, Croatia

🇳🇱

Universitair Medisch Centrum St. Radboud - Nijmegen, Nijmegen, Netherlands

🇧🇪

Algemeen Ziekenhuis Sint-Augustinus, Wilrijk, Belgium

and more 3 locations
© Copyright 2025. All Rights Reserved by MedPath